Novavax Inc
Change company Symbol lookup
Select an option...
NVAX Novavax Inc
ICLK iClick Interactive Asia Group Ltd
BSQR Bsquare Corp
BLDP Ballard Power Systems Inc
FOX Fox Corp
JNJ Johnson & Johnson
ERBB American Green Inc
PEGA Pegasystems Inc
NDRA ENDRA Life Sciences Inc
HIG-G Hartford Financial Services Group Inc
Go

Health Care : Biotechnology | Mid Cap Growth
Company profile

Novavax, Inc. is a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants. The Company operates through developing recombinant vaccines segment. The Company, through its recombinant nanoparticle vaccine technology, produces vaccine candidates to respond to both known and newly emerging diseases. The Company's product pipeline focuses on a range of infectious diseases with vaccine candidates in clinical development for respiratory syncytial virus (RSV), seasonal influenza, pandemic influenza and the Ebola virus (EBOV). The Company's lead adjuvant for human applications, Matrix-M, is in a Phase I/II clinical trial for pandemic influenza H7N9 vaccine candidate. It is also testing Matrix-M in conjunction with its EBOV vaccine candidate in a Phase I clinical trial. It is developing additional pre-clinical stage programs in a range of infectious diseases, including Middle East respiratory syndrome (MERS).

Price
Delayed
$81.89
Day's Change
2.42 (3.05%)
Bid
--
Ask
--
B/A Size
--
Day's High
86.88
Day's Low
77.90
Volume
(Heavy Day)

Today's volume of 954,477 shares is on pace to be much greater than NVAX's 10-day average volume of 7,006,528 shares.

954,477
  • Prev Close
    79.47
  • Today's Open
    78.46
  • Day's Range
    77.90-86.88
  • Avg Vol (10-day)
    7.0M
  • Last (time)
    9:40a ET 01/25/22
  • Last (size)
    100
  • 52-Wk Range
    66.38 - 331.68
    LowHigh
  • (02/09/21 - 01/24/22)
    23.37%
  • 118.3%
  • Market Cap
    6.2B
  • Shares Outstanding
    75.6M
  • -14.82
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.4
  • 47.34
  • (% of float 12/31/21)
    11.89

Latest News

January 24, 2022
5:14 pm ET
MarketWatch
January 21, 2022
5:14 pm ET
MarketWatch
January 20, 2022
5:14 pm ET
MarketWatch
January 19, 2022
5:14 pm ET
MarketWatch
January 18, 2022
10:06 am ET
MarketWatch
January 14, 2022
5:14 pm ET
MarketWatch
10:30 am ET
PR Newswire
January 13, 2022
5:14 pm ET
MarketWatch
9:00 am ET
PR Newswire
January 12, 2022
5:14 pm ET
MarketWatch
10:10 am ET
MarketWatch
6:10 am ET
MarketWatch
6:03 am ET
MarketWatch
January 11, 2022
5:26 pm ET
Newsfile
5:14 pm ET
MarketWatch
2:55 pm ET
Accesswire
1:03 pm ET
Newsfile
11:00 am ET
BusinessWire
9:00 am ET
PR Newswire
7:30 am ET
Accesswire
January 10, 2022
7:45 pm ET
Accesswire
5:24 pm ET
Newsfile
5:14 pm ET
MarketWatch
3:01 pm ET
Accesswire
1:01 pm ET
Newsfile
12:57 pm ET
PR Newswire
11:00 am ET
Accesswire
10:11 am ET
Accesswire
9:00 am ET
Globe Newswire
7:45 am ET
Accesswire
January 09, 2022
11:55 pm ET
Newsfile
9:00 pm ET
BusinessWire
8:51 pm ET
Accesswire
5:37 pm ET
Newsfile
5:19 pm ET
Globe Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.